Evaluation of the Antibacterial Effect of a Toothpaste Containing Zinc Lactate
Study Details
Study Description
Brief Summary
The aim of this study is to evaluate the antibacterial effect 12 hours after 4-week use of a toothpaste containing amine base, zinc lactate, and fluoride. For this, healthy people will be invited to use two different toothpaste: control - containing only fluoride; test - containing fluoride plus a combination with zinc. The primary outcome is the efficacy of the test toothpaste in the oral bacterial load reduction in samples of saliva and oral mucosa (obtained through scraping); the second outcome is effect of the test toothpaste in the expression of mucin in the oral mucosa.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 3 |
Detailed Description
Study Design This is a phase III, randomized, single center, parallel-group, double-blind clinical study to evaluate the antibacterial effect of a toothpaste containing an amine, zinc lactate, and fluoride base.
Primary Objective The objective of this study is to evaluate the antibacterial effect 12 hours after using a toothpaste containing amine, zinc lactate and fluoride for 4 weeks.
Secondary Objectives The secondary objective will be to evaluate the impact of a toothpaste containing amine, zinc lactate and fluoride in the quantification of mucin on the surface of the oral mucosa.
Study Intervention Design: Parallel Product Assignment: Randomization Number of individuals:
130 Individuals by age group: 18 to 70 Number of test groups: 2 Treatment regimen: Brushing of the entire mouth with test toothpaste Blind Mode: Double-blind Number of exposures (uses): Twice a day, unattended Study duration: 6 weeks Washout period: Yes Duration of each exposure: 2 minutes of brushing
Study Groups:
- Test Group: Toothpaste containing amine base, zinc lactate and fluorine (1400 ppm F).
C
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Placebo Comparator: Fluoride toothpaste Participants will brush their teeth with a commercially available Fluoride toothpaste (1450 ppm F) and a commercially available adult soft bristle toothbrush |
Combination Product: Fluoride Toothpaste
Participants will brush their teeth with a commercially available, soft-bristle adult toothbrush and toothpaste containing fluoride (1450 ppm F).
|
Experimental: Zinc toothpaste Participants will brush their teeth with a toothpaste containing amine base, zinc lactate and fluoride (1400 ppm F) and a commercially available adult soft bristle toothbrush |
Combination Product: Zinc toothpaste
Participants will brush their teeth with a commercially available, soft-bristle adult toothbrush and toothpaste containing amine-based zinc lactate (0.1%) and fluoride (1400 ppm F).
|
Outcome Measures
Primary Outcome Measures
- Change of oral bacteria load [Baseline (previously of the interventions) and after 4 weeks of the interventions]
analysis of oral bacterial load (log10 colony-forming unit/mL) in saliva and oral mucosa biofilm samples, performed by microbial culture
Secondary Outcome Measures
- Change of mucin expression in oral mucosa samples [Baseline (previously of the interventions) and after 1, 2, 3 and 4 weeks of the interventions]
quantification of mucin expression produced by the mucin gene (pg/mL) present in samples of the jugal mucosa, performed by means of an ELISA immunoenzymatic test.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Male and female subjects, ages 18-70, inclusive;
-
Subjects are available during study duration;
-
Subject is in good general health;
-
A minimum of 15 natural teeth with facial and lingual scorable surfaces, excluding third molars.
-
A willingness to read, understand, and sign the Informed Consent Form after the nature of the study has been fully explained to them.
-
Subjects with baseline whole mouth scores of dental plaque of 1.5 or more and gingivitis index of 1.0 or more.
Exclusion Criteria:
-
Participation in any other clinical study or test panel including clinical studies with oral hygiene formulations within the one month prior to entry into the study.
-
History of dental prophylaxis or treatments in the past month or during study duration.
-
History of medical treatments (e.g: antibiotic, anti-inflammatory, anticoagulant, etc.) during the month preceding study enrollment.
-
Subjects scheduled for any medical procedure during the course of the study.
-
Difficulty complying with study procedures and examinations such as excessive gagging during oral assessment etc.
-
History of significant adverse effects following use of oral hygiene products such as toothpastes and mouthrinses. Allergies to personal care/consumer products or their ingredients.
-
History of diabetes, hepatic, renal disease, inflammatory conditions or transmittable diseases, e.g. heart disease or AIDS.
-
History of rheumatic fever or medical conditions that require prophylactic antibiotics coverage prior to dental procedures.
-
Presence of oral lesions.
-
History of active or severe periodontal disease (PD > 4) and loose teeth.
-
Gross dental caries, severe generalized cervical abrasion and/or enamel abrasion, large fractured or temporary restorations (based on visual examinations).
-
Fixed or removable orthodontic appliances or removable partial dentures.
-
Current smokers and subjects with a history of alcohol or drug abuse.
-
Use of phenolic flavored products, such as mint flavored candies and chewing gum, during the study period.
-
Unable to refrain from oral hygiene for twelve (12) hours prior to scheduled visits.
-
Positive Coronavirus Disease 2019 test 48 hours prior to the screening visit.
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Hospital Israelita Albert Einstein
- Colgate Palmolive
- Associação Latinoamericana para Promoção de Saúde Bucal e Pesquisa Odontológica (LAOHA)
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
- Aguirre A, Mendoza B, Levine MJ, Hatton MN, Douglas WH. In vitro characterization of human salivary lubrication. Arch Oral Biol. 1989;34(8):675-7. doi: 10.1016/0003-9969(89)90024-1.
- Ben Lagha A, Yang Y, Trivedi HM, Masters JG, Grenier D. A Dual Zinc plus Arginine formulation attenuates the pathogenic properties of Porphyromonas gingivalis and protects gingival keratinocyte barrier function in an in vitro model. J Oral Microbiol. 2020 Aug 4;12(1):1798044. doi: 10.1080/20002297.2020.1798044. Erratum In: J Oral Microbiol. 2020 Sep 2;12(1):1813916.
- Carda-Dieguez M, Moazzez R, Mira A. Functional changes in the oral microbiome after use of fluoride and arginine containing dentifrices: a metagenomic and metatranscriptomic study. Microbiome. 2022 Sep 28;10(1):159. doi: 10.1186/s40168-022-01338-4.
- Creeth JE, Karwal R, Hara AT, Zero DT. A Randomized in situ Clinical Study of Fluoride Dentifrices on Enamel Remineralization and Resistance to Demineralization: Effects of Zinc. Caries Res. 2018;52(1-2):129-138. doi: 10.1159/000479823. Epub 2018 Jan 5.
- Delgado E, Garcia-Godoy F, Montero-Aguilar M, Mateo LR, Ryan M. A Clinical Investigation of a Dual Zinc plus Arginine Dentifrice in Reducing Established Dental Plaque and Gingivitis Over a Six-Month Period of Product Use. J Clin Dent. 2018 Sep;29(Spec No A):A33-40.
- Kindblom C, Davies JR, Herzberg MC, Svensater G, Wickstrom C. Salivary proteins promote proteolytic activity in Streptococcus mitis biovar 2 and Streptococcus mutans. Mol Oral Microbiol. 2012 Oct;27(5):362-72. doi: 10.1111/j.2041-1014.2012.00650.x. Epub 2012 May 25.
- Manus LM, Daep CA, Begum-Gafur R, Makwana E, Won B, Yang Y, Huang XY, Maloney V, Trivedi HM, Wu D, Masters JG. Enhanced In Vitro Zinc Bioavailability through Rational Design of a Dual Zinc plus Arginine Dentifrice. J Clin Dent. 2018 Sep;29(Spec No A):A10-19.
- CRO-2022-05-MC-MD-BZ-BS